Valproid acid plus corticosteroids ( DrugBank: - )
1 disease
| ID | Disease name (Link within this page) | Number of trials |
|---|---|---|
| 26 | HTLV-1-associated myelopathy | 1 |
26. HTLV-1-associated myelopathy
Clinical trials : 28 / Drugs : 48 - (DrugBank : 28) / Drug target genes : 38 - Drug target pathways : 127
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | NCT00681980 (ClinicalTrials.gov) | February 2008 | 19/5/2008 | Use Of Valproid Acid To Treat Tropical Spastic Paraparesis/HTLV-1-Associated Myelopathy (TSP/HAM) | Study Of Valproic Acid To Treat TSP/HAM Patients In Sao Paulo, Brazil | Paraparesis Spastic Tropical | Drug: Valproic acid;Drug: costicosteroids;Drug: valproid acid plus corticosteroids | University of Sao Paulo | NULL | Completed | 18 Years | 70 Years | Both | 60 | Phase 3 | Brazil |